Allegiance Financial Group Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,353
Closed -$365K 156
2025
Q1
$365K Buy
1,353
+384
+40% +$104K 0.11% 74
2024
Q4
$228K Buy
+969
New +$228K 0.07% 88